Online first
Case report
Published online: 2024-01-24
Eosinophilic fasciitis — a case report
DOI: 10.5603/rf.96786
Abstract
Eosinophilic fasciitis (EF) is a rare disease. The case of a patient who was treated with immunosuppressive therapy with methotrexate and methylprednisolone was presented. The aetiology of the disease, diagnostic difficulties and treatment were also discussed.
Keywords: eosinophilic fasciitis
References
- Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians. 1975; 88: 70–86.
- Niklas K, Niklas A, Puszczewicz M. Eosinophilic fasciitis. Postępy Higieny i Medycyny Doświadczalnej. 2015; 69: 488–495.
- Mazilu D, Boltașiu Tătaru LA, Mardale DA, et al. Eosinophilic Fasciitis: Current and Remaining Challenges. Int J Mol Sci. 2023; 24(3).
- Bobrowska-Snarska D, Ostanek L, Brzosko M. [Eosinophilic fasciitis--diagnostic and therapeutic difficulties]. Ann Acad Med Stetin. 2008; 54(2): 47–51.
- Bobrowska-Snarska D, Ostanek L, Brzosko M. Fasciitis eosinophilica: personal observations and a review of the literature. Pol Arch Med Wewn. 2007; 117(4): 184–191.
- Puszczewicz M, Zimmermann-Górska I, Pietrzak-Kaczmarek H, et al. [Diagnostic problems in eosinophilic fasciitis]. Pol Arch Med Wewn. 2006; 116(2): 777–780.
- Ząber K, Niećko UK, Tytoń J, et al. Eozynofilowe zapalenie powięzi. Forum Reumatol. 2020; 6(1): 45–50.
- Lebeaux D, Francès C, Barete S, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford). 2012; 51(3): 557–561.
- Macklin M, Yadav S, Jan R, et al. Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics. Pharmaceuticals (Basel). 2023; 16(2).
- Ihn H. Eosinophilic fasciitis: From pathophysiology to treatment. Allergol Int. 2019; 68(4): 437–439.
- Lan TY, Wang ZH, Kong WP, et al. Eosinophilic fasciitis difficult to differentiate from scleroderma: A case report. World J Clin Cases. 2023; 11(13): 3092–3098.
- Mazori DR, Femia AN, Vleugels RA. Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment. Curr Rheumatol Rep. 2017; 19(12): 74.
- Kucharz EJ, Sierakowski SJ. Zespoły przypominające twardzinę układową wywołane przez czynniki chemiczne. Przegl Lek. 1987; 44: 666–671.
- Pinal-Fernandez I, Callejas-Moraga EL, Roade-Tato ML, et al. Groove sign in eosinophilic fasciitis. Lancet. 2014; 384(9956): 1774.
- Pinal-Fernandez I, Selva-O Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev. 2014; 13(4–5): 379–382.
- Samborski W, Żaba R. Zastosowanie dożylnej pulsacyjnej terapii glikokortykosteroidami u chorego na eozynofilowe zapalenie powięzi. Dermatol Klin. 2000; 2: 33–36.
